Author

L. Stern

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Research Focus:clustering· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A. Abendroth· 1 shared A. Park· 1 shared A. R. Henry· 1 shared A. S. De Groot· 1 shared A. S. Fahad· 1 shared B. F. Fazekas de St Groth· 1 shared B. Gittins· 1 shared B. J. DeKosky· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Abendroth

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting

E. Lee, C. Cullen, J. P. Murad, D. Gumber, A. Park, J. Yang, L. Stern, L. Adkins, G. Dhapola, B. Gittins, W.-C. Chang, C. Martinez, Y. Woo, M. Cristea, L. Rodriguez, , S. J. Priceman

This study develops TAG72-CAR T cells with antigen-dependent IL-12 signaling to enhance anti-tumor activity and systemic disease targeting in ovarian cancer.

bioRxiv · Jan 6, 2023 · PreprintCancer Biology

Immune Cell Profiling Reveals MAIT and Effector Memory CD4+ T Cell Recovery Link to Control of Cytomegalovirus Reactivation after Stem Cell Transplant

L. Stern, H. M. McGuire, S. Avdic, B. F. Fazekas de St Groth, D. Gottlieb, A. Abendroth, E. Blyth, B. Slobedman

The paper identifies immune cell signatures linked to HCMV reactivation control after stem cell transplant, showing MAIT cell levels and effector-memory CD4+ T cell recovery as prognostic markers.

bioRxiv · Aug 9, 2021 · PreprintImmunology

Human antibody immune responses are personalized by selective removal of MHC-II peptide epitopes

M. Gutierrez-Gonzalez, A. S. Fahad, M. Ardito, P. Nanaware, L. Lu, E. Normandin, B. Madan, J. Tivin, E. Coates, A. R. Henry, F. Laboune, B. S. Graham, D. C. Douek, J. E. Ledgerwood, J. R. Mascola, , B. J. DeKosky

The paper shows that MHC-II epitope removal from BCRs correlates with antibody development, T cell help, and long-term serum antibody secretion.

bioRxiv · Jan 15, 2021 · PreprintImmunology